UCB Announces Divestment of Celltech Manufacturing Services

30-Aug-2005

UCB announced the divestment of Celltech Manufacturing Services Ltd, in Ashton, UK, a UCB subsidiary carrying out contract manufacturing. The subsidiary has been acquired by US company Inyx Incorporated for 27.5 million Euros. Inyx is a speciality pharmaceutical company focusing on niche drug delivery technologies.

Other news from the department business & finance

Most read news

More news from our other portals

Fighting cancer: latest developments and advances